Cargando…
Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020
ABSTRACT: Recent advances have shown impressive results by anti-interleukin 1 (IL-1) agents in refractory idiopathic recurrent pericarditis. PURPOSE OF REVIEW: We critically discuss the current state of the art of therapy of relapsing pericarditis, with a focus on new pharmacological approaches and...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303578/ https://www.ncbi.nlm.nih.gov/pubmed/32562029 http://dx.doi.org/10.1007/s11886-020-01308-y |